by Benzinga Insights | Mar 26, 2026 | General
Terns Pharma (NASDAQ:TERN) has outperformed the market over the past 5 years by 8.99% on an annualized basis producing an average annual return of 19.31%. Currently, Terns Pharma has a market capitalization of $6.01 billion. Buying $1000 In TERN: If an investor had...
by Benzinga Insights | Mar 26, 2026 | General
JPMorgan Chase (NYSE:JPM) has outperformed the market over the past 15 years by 1.95% on an annualized basis producing an average annual return of 13.05%. Currently, JPMorgan Chase has a market capitalization of $789.56 billion. Buying $100 In JPM: If an investor had...
by Benzinga Insights | Mar 26, 2026 | General
Applied Materials (NASDAQ:AMAT) has outperformed the market over the past 15 years by 11.72% on an annualized basis producing an average annual return of 22.81%. Currently, Applied Materials has a market capitalization of $271.06 billion. Buying $1000 In AMAT: If an...
by Benzinga Insights | Mar 26, 2026 | General
United States Oil Fund (NYSE:USO) has outperformed the market over the past 5 years by 12.96% on an annualized basis producing an average annual return of 23.29%. Currently, United States Oil Fund has a market capitalization of $2.34 billion. Buying $1000 In USO: If...
by Chandrima Sanyal | Mar 26, 2026 | General
The AI boom has thus far been characterized by the increasing demand for chips and cloud infrastructure, but the latest collaboration between Microsoft Corp (NASDAQ:MSFT) and Nvidia Corp (NASDAQ:NVDA) is set to push the narrative of this boom to the next level:...
Recent Comments